drugset / Trial / NCT02215954

A Phase III Study With FE 999169 Versus Niflec for Colon Cleansing

NCT02215954 ↗

Phase 3 Completed 637 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

To demonstrate non inferiority of a) "FE 999169 Split Dosing Schedule" (one dose on the day before and the second dose on the day of colonoscopy) and b) "FE 999169 Day Before Dosing Schedule" (two doses on the day before colonoscopy) to " Niflec On the Day Dosing Schedule" in subjects requiring colonoscopy.

Timeline

Start
2014-09
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject FE 999169 Unknown 16.1 g Oral
Comparator Niflec Unknown 137.155 g Oral

Indications

No indication recorded.